相似文献
1
Clinical reasoning: a 56-year-old man with progressive spasticity.
Neurology. 2013 Feb 26;80(9):e84-8. doi: 10.1212/WNL.0b013e3182840729.
2
Female carriers of X-chromosomal adrenoleukodystrophy: a major differential diagnosis in progressive myelopathy.
J Neurol. 2010 Aug;257(8):1394-5. doi: 10.1007/s00415-010-5505-8. Epub 2010 Mar 2.
3
Clinical utility gene card for: adrenoleukodystrophy.
Eur J Hum Genet. 2012 Mar;20(3). doi: 10.1038/ejhg.2011.193. Epub 2011 Nov 9.
4
A novel missense mutation in the ABCD1 gene of a Chinese boy diagnosed with X-linked adrenoleukodystrophy: case report.
Neurol Sci. 2019 May;40(5):1093-1096. doi: 10.1007/s10072-018-3596-7. Epub 2018 Oct 20.
5
[X-linked adrenoleukodystrophy (X-ALD)].
Rofo. 2011 Dec;183(12):1093-6. doi: 10.1055/s-0031-1295619.
6
X-linked adrenoleukodystrophy.
Ann N Y Acad Sci. 1996 Dec 27;804:461-76. doi: 10.1111/j.1749-6632.1996.tb18637.x.
7
A case of adult-onset adrenoleukodystrophy with frontal lobe dysfunction: a novel point mutation in the ABCD1 gene.
Intern Med. 2012;51(11):1403-6. doi: 10.2169/internalmedicine.51.6899. Epub 2012 Jun 1.
8
Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.
Neurology. 2019 Jul 9;93(2):81-84. doi: 10.1212/WNL.0000000000007755.
9
Granny trips down: is she carrying the big bad wolf?
Neurol Sci. 2013 Nov;34(11):2077-9. doi: 10.1007/s10072-012-1108-8. Epub 2012 May 17.
10
X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?
Glia. 2000 Jan 15;29(2):186-90. doi: 10.1002/(sici)1098-1136(20000115)29:2<186::aid-glia13>3.0.co;2-5.
本文引用的文献
1
Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
Methods Enzymol. 2012;507:187-98. doi: 10.1016/B978-0-12-386509-0.00010-7.
2
Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated.
Mol Genet Metab. 2012 Feb;105(2):180-5. doi: 10.1016/j.ymgme.2011.11.001. Epub 2011 Nov 10.
3
Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.
Eur J Pediatr. 2011 Aug;170(8):1049-54. doi: 10.1007/s00431-011-1401-1. Epub 2011 Jan 29.
4
Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.
Brain Pathol. 2010 Jul;20(4):857-62. doi: 10.1111/j.1750-3639.2010.00394.x.
5
Biochemical aspects of X-linked adrenoleukodystrophy.
Brain Pathol. 2010 Jul;20(4):831-7. doi: 10.1111/j.1750-3639.2010.00391.x.
6
"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
J Mol Neurosci. 2007 Sep;33(1):105-13. doi: 10.1007/s12031-007-0041-4.
7
X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.
Biochim Biophys Acta. 2006 Dec;1763(12):1721-32. doi: 10.1016/j.bbamcr.2006.07.010. Epub 2006 Jul 26.
8
Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy.
Mol Genet Metab. 1999 Feb;66(2):128-36. doi: 10.1006/mgme.1998.2779.
9
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
J Clin Endocrinol Metab. 1996 Feb;81(2):470-4. doi: 10.1210/jcem.81.2.8636252.
Zotero 插件